Free Trial
OTCMKTS:XSNX

NovAccess Global 8/11/2023 Earnings Report

NovAccess Global logo
$0.0004 0.00 (0.00%)
As of 04/24/2025

NovAccess Global EPS Results

Actual EPS
-$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NovAccess Global Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NovAccess Global Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NovAccess Global Earnings Headlines

Global wage calculator: Compare your salary
NovAccess Global Inc.
From Social Security to Social Prosperity?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
NovAccess Global Inc. (XSNX)
See More NovAccess Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NovAccess Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovAccess Global and other key companies, straight to your email.

About NovAccess Global

NovAccess Global (OTCMKTS:XSNX), a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

View NovAccess Global Profile

More Earnings Resources from MarketBeat